Unyvero A50 UTI
Urinary tract infections
CommercialMarketed (CE-Marked)
Key Facts
About OpGen
OpGen is a US-based public company focused on addressing the global antimicrobial resistance (AMR) crisis through advanced diagnostics and data analytics. Its core offerings include the Acuitas AMR Gene Panel and the Unyvero platform for rapid detection of pathogens and resistance markers. The company's strategy involves integrating molecular diagnostics with bioinformatics to guide targeted antibiotic therapy and support infection control programs in hospitals.
View full company profile